organic compounds
5-Methyl-N-[2-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
aState Key Laboratory of Materials-Oriented Chemical Engineering, School of Pharmaceutical Sciences, Nanjing University of Technology, Xinmofan Road No.5 Nanjing, Nanjing 210009, People's Republic of China
*Correspondence e-mail: dc_wang@hotmail.com
In the title compound, C12H9F3N2O2, the benzene ring is nearly perpendicular to the isoxazole ring, making a dihedral angle of 82.97 (2)°. In the crystal, molecules are linked by N—H⋯O hydrogen bonds into a supramolecular chain running along the c axis.
Related literature
For applications of leflunomide [systematic name: 5-methyl-N-[4-(trifluoromethyl) phenyl]-isoxazole-4-carboxamide] in the treatment of rheumatoid arthritis, see: Shaw et al. (2011); Schattenkirchner (2000). For leflunomide analogs, see: Huang et al. (2003); Wang et al. (2011).
Experimental
Crystal data
|
Refinement
|
Data collection: CAD-4 EXPRESS (Enraf–Nonius, 1994); cell CAD-4 EXPRESS; data reduction: XCAD4 (Harms & Wocadlo,1995); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.
Supporting information
10.1107/S1600536812016467/xu5516sup1.cif
contains datablocks I, global. DOI:Structure factors: contains datablock I. DOI: 10.1107/S1600536812016467/xu5516Isup2.hkl
Supporting information file. DOI: 10.1107/S1600536812016467/xu5516Isup3.cml
A solution of 0.05 mole of 5-methylisoxazole-4-carboxylic acid chloride (7.3 g) in 20 ml of acetonitrile is added drop-wise, while stirring, to 0.1 mole of 2-(trifluoromethyl)aniline (16.1g),dissolved in 150 ml of acetonitrile at room temperature.After stirring for 40 minutes, the precipitated 2-(trifluoromethyl)aniline hydrochloride is filtered off and washed with 100 ml portions of acetonitrile, and the combined filtrates are concentrated under reduced pressure.9.6g(69.51% of theory) of white crystalline 5-methyl-N-(2-(trifluoromethyl)phenyl)isoxazole-4- carboxamide are thus obtained. Crystals of (I) suitable for X-ray diffraction were obtained by slow evaporation of an methylbenzene solution.
H atoms were placed at calculated positions and were treated as riding on the parent C or N atoms with C—H = 0.96 (methyl), 0.97 (methylene) and N—H = 0.86 Å, Uiso(H) = 1.2 or 1.5 Ueq(C,N).
Data collection: CAD-4 EXPRESS (Enraf–Nonius, 1994); cell
CAD-4 EXPRESS (Enraf–Nonius, 1994); data reduction: XCAD4 (Harms & Wocadlo,1995); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).Fig. 1. The structure of the title compound, showing the atomic numbering scheme. Non-H atoms are shown with 30% probability displacement ellipsoids. |
C12H9F3N2O2 | F(000) = 552 |
Mr = 270.21 | Dx = 1.472 Mg m−3 |
Monoclinic, P21/c | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2ybc | Cell parameters from 25 reflections |
a = 15.839 (3) Å | θ = 9–13° |
b = 8.3260 (17) Å | µ = 0.13 mm−1 |
c = 9.4250 (19) Å | T = 293 K |
β = 101.29 (3)° | Block, colorless |
V = 1218.9 (4) Å3 | 0.20 × 0.10 × 0.10 mm |
Z = 4 |
Enref–Nonius CAD-4 diffractometer | 1125 reflections with I > 2σ(I) |
Radiation source: fine-focus sealed tube | Rint = 0.000 |
Graphite monochromator | θmax = 25.2°, θmin = 1.3° |
ω/2θ scans | h = −18→18 |
Absorption correction: ψ scan (North et al., 1968) | k = 0→9 |
Tmin = 0.974, Tmax = 0.987 | l = 0→11 |
2193 measured reflections | 3 standard reflections every 200 reflections |
2193 independent reflections | intensity decay: 1% |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.062 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.164 | H-atom parameters constrained |
S = 1.00 | w = 1/[σ2(Fo2) + (0.068P)2] where P = (Fo2 + 2Fc2)/3 |
2193 reflections | (Δ/σ)max < 0.001 |
172 parameters | Δρmax = 0.19 e Å−3 |
0 restraints | Δρmin = −0.19 e Å−3 |
C12H9F3N2O2 | V = 1218.9 (4) Å3 |
Mr = 270.21 | Z = 4 |
Monoclinic, P21/c | Mo Kα radiation |
a = 15.839 (3) Å | µ = 0.13 mm−1 |
b = 8.3260 (17) Å | T = 293 K |
c = 9.4250 (19) Å | 0.20 × 0.10 × 0.10 mm |
β = 101.29 (3)° |
Enref–Nonius CAD-4 diffractometer | 1125 reflections with I > 2σ(I) |
Absorption correction: ψ scan (North et al., 1968) | Rint = 0.000 |
Tmin = 0.974, Tmax = 0.987 | 3 standard reflections every 200 reflections |
2193 measured reflections | intensity decay: 1% |
2193 independent reflections |
R[F2 > 2σ(F2)] = 0.062 | 0 restraints |
wR(F2) = 0.164 | H-atom parameters constrained |
S = 1.00 | Δρmax = 0.19 e Å−3 |
2193 reflections | Δρmin = −0.19 e Å−3 |
172 parameters |
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
N1 | 0.73554 (18) | 0.2300 (3) | 0.9712 (3) | 0.0540 (8) | |
H1A | 0.7386 | 0.2533 | 1.0610 | 0.065* | |
O1 | 0.67807 (16) | 0.2925 (3) | 0.7394 (2) | 0.0647 (8) | |
F1 | 0.9108 (2) | 0.3541 (4) | 1.0116 (3) | 0.1322 (13) | |
C1 | 0.9018 (3) | −0.0106 (6) | 0.8447 (4) | 0.0732 (12) | |
H1B | 0.9526 | 0.0039 | 0.8108 | 0.088* | |
O2 | 0.55089 (19) | 0.6534 (3) | 0.9342 (3) | 0.0782 (9) | |
N2 | 0.6083 (3) | 0.6480 (4) | 1.0694 (4) | 0.0790 (11) | |
F2 | 0.97802 (18) | 0.2773 (4) | 0.8551 (4) | 0.1233 (11) | |
C2 | 0.8701 (3) | −0.1615 (6) | 0.8525 (5) | 0.0844 (14) | |
H2B | 0.8989 | −0.2489 | 0.8232 | 0.101* | |
F3 | 0.85728 (19) | 0.3827 (3) | 0.7915 (3) | 0.1128 (10) | |
C3 | 0.7957 (3) | −0.1853 (5) | 0.9035 (5) | 0.0805 (13) | |
H3A | 0.7746 | −0.2886 | 0.9103 | 0.097* | |
C4 | 0.7526 (3) | −0.0551 (5) | 0.9447 (4) | 0.0650 (11) | |
H4A | 0.7023 | −0.0707 | 0.9797 | 0.078* | |
C5 | 0.7837 (2) | 0.0983 (4) | 0.9344 (3) | 0.0512 (9) | |
C6 | 0.8601 (2) | 0.1205 (5) | 0.8858 (4) | 0.0574 (10) | |
C7 | 0.9005 (3) | 0.2832 (5) | 0.8849 (5) | 0.0680 (11) | |
C8 | 0.6852 (2) | 0.3198 (4) | 0.8696 (4) | 0.0486 (9) | |
C9 | 0.6396 (2) | 0.4541 (4) | 0.9236 (4) | 0.0488 (9) | |
C10 | 0.5722 (3) | 0.5371 (5) | 0.8487 (4) | 0.0589 (10) | |
C11 | 0.6589 (3) | 0.5281 (5) | 1.0597 (4) | 0.0641 (11) | |
H11A | 0.7029 | 0.4948 | 1.1343 | 0.077* | |
C12 | 0.5197 (3) | 0.5268 (5) | 0.7026 (4) | 0.0761 (12) | |
H12A | 0.4770 | 0.6101 | 0.6897 | 0.114* | |
H12B | 0.4919 | 0.4240 | 0.6897 | 0.114* | |
H12C | 0.5559 | 0.5397 | 0.6327 | 0.114* |
U11 | U22 | U33 | U12 | U13 | U23 | |
N1 | 0.066 (2) | 0.0617 (19) | 0.0402 (15) | 0.0153 (17) | 0.0235 (14) | 0.0065 (15) |
O1 | 0.0783 (18) | 0.0810 (19) | 0.0400 (13) | 0.0171 (15) | 0.0239 (12) | −0.0014 (13) |
F1 | 0.172 (3) | 0.127 (3) | 0.112 (2) | −0.071 (2) | 0.062 (2) | −0.0454 (19) |
C1 | 0.064 (3) | 0.081 (3) | 0.083 (3) | 0.013 (2) | 0.035 (2) | 0.003 (2) |
O2 | 0.093 (2) | 0.0569 (17) | 0.094 (2) | 0.0188 (16) | 0.0402 (19) | 0.0020 (16) |
N2 | 0.111 (3) | 0.063 (2) | 0.069 (2) | 0.010 (2) | 0.035 (2) | −0.0060 (19) |
F2 | 0.0791 (18) | 0.124 (2) | 0.182 (3) | −0.0192 (18) | 0.0619 (19) | 0.010 (2) |
C2 | 0.091 (3) | 0.071 (3) | 0.100 (4) | 0.022 (3) | 0.040 (3) | 0.003 (3) |
F3 | 0.108 (2) | 0.087 (2) | 0.135 (3) | −0.0171 (17) | 0.0032 (18) | 0.0453 (18) |
C3 | 0.097 (3) | 0.049 (3) | 0.102 (3) | 0.003 (2) | 0.034 (3) | 0.014 (2) |
C4 | 0.065 (3) | 0.068 (3) | 0.070 (3) | −0.001 (2) | 0.033 (2) | 0.015 (2) |
C5 | 0.059 (2) | 0.054 (2) | 0.045 (2) | 0.0066 (19) | 0.0234 (18) | 0.0067 (16) |
C6 | 0.058 (2) | 0.069 (3) | 0.050 (2) | 0.006 (2) | 0.0218 (18) | 0.0051 (19) |
C7 | 0.065 (3) | 0.075 (3) | 0.071 (3) | 0.000 (2) | 0.033 (2) | 0.004 (2) |
C8 | 0.050 (2) | 0.049 (2) | 0.052 (2) | 0.0024 (18) | 0.0254 (17) | 0.0047 (17) |
C9 | 0.061 (2) | 0.044 (2) | 0.0470 (19) | −0.0004 (18) | 0.0261 (17) | 0.0010 (17) |
C10 | 0.064 (3) | 0.049 (2) | 0.070 (2) | −0.004 (2) | 0.030 (2) | 0.004 (2) |
C11 | 0.091 (3) | 0.056 (2) | 0.051 (2) | 0.003 (2) | 0.026 (2) | 0.0006 (19) |
C12 | 0.076 (3) | 0.072 (3) | 0.081 (3) | −0.001 (2) | 0.017 (2) | 0.015 (2) |
N1—C8 | 1.346 (4) | C3—C4 | 1.377 (5) |
N1—C5 | 1.417 (4) | C3—H3A | 0.9300 |
N1—H1A | 0.8600 | C4—C5 | 1.379 (5) |
O1—C8 | 1.231 (4) | C4—H4A | 0.9300 |
F1—C7 | 1.314 (4) | C5—C6 | 1.387 (4) |
C1—C2 | 1.361 (6) | C6—C7 | 1.499 (5) |
C1—C6 | 1.370 (5) | C8—C9 | 1.475 (4) |
C1—H1B | 0.9300 | C9—C10 | 1.350 (5) |
O2—C10 | 1.345 (4) | C9—C11 | 1.401 (5) |
O2—N2 | 1.415 (4) | C10—C12 | 1.465 (5) |
N2—C11 | 1.295 (5) | C11—H11A | 0.9300 |
F2—C7 | 1.312 (4) | C12—H12A | 0.9600 |
C2—C3 | 1.370 (6) | C12—H12B | 0.9600 |
C2—H2B | 0.9300 | C12—H12C | 0.9600 |
F3—C7 | 1.302 (5) | ||
C8—N1—C5 | 121.8 (3) | F3—C7—F1 | 106.5 (4) |
C8—N1—H1A | 119.1 | F2—C7—F1 | 104.9 (4) |
C5—N1—H1A | 119.1 | F3—C7—C6 | 114.2 (4) |
C2—C1—C6 | 121.1 (4) | F2—C7—C6 | 112.7 (4) |
C2—C1—H1B | 119.5 | F1—C7—C6 | 112.2 (3) |
C6—C1—H1B | 119.5 | O1—C8—N1 | 122.2 (3) |
C10—O2—N2 | 108.9 (3) | O1—C8—C9 | 121.8 (3) |
C11—N2—O2 | 105.0 (3) | N1—C8—C9 | 115.9 (3) |
C1—C2—C3 | 120.3 (4) | C10—C9—C11 | 105.2 (3) |
C1—C2—H2B | 119.9 | C10—C9—C8 | 126.8 (3) |
C3—C2—H2B | 119.9 | C11—C9—C8 | 128.0 (4) |
C2—C3—C4 | 119.5 (4) | O2—C10—C9 | 108.7 (3) |
C2—C3—H3A | 120.3 | O2—C10—C12 | 116.3 (4) |
C4—C3—H3A | 120.3 | C9—C10—C12 | 135.0 (4) |
C3—C4—C5 | 120.4 (3) | N2—C11—C9 | 112.2 (4) |
C3—C4—H4A | 119.8 | N2—C11—H11A | 123.9 |
C5—C4—H4A | 119.8 | C9—C11—H11A | 123.9 |
C4—C5—C6 | 119.5 (3) | C10—C12—H12A | 109.5 |
C4—C5—N1 | 118.9 (3) | C10—C12—H12B | 109.5 |
C6—C5—N1 | 121.6 (3) | H12A—C12—H12B | 109.5 |
C1—C6—C5 | 119.2 (4) | C10—C12—H12C | 109.5 |
C1—C6—C7 | 119.2 (3) | H12A—C12—H12C | 109.5 |
C5—C6—C7 | 121.6 (3) | H12B—C12—H12C | 109.5 |
F3—C7—F2 | 105.6 (3) | ||
C10—O2—N2—C11 | −1.6 (4) | C1—C6—C7—F1 | −123.8 (4) |
C6—C1—C2—C3 | −0.7 (7) | C5—C6—C7—F1 | 52.7 (5) |
C1—C2—C3—C4 | 1.0 (7) | C5—N1—C8—O1 | 0.1 (5) |
C2—C3—C4—C5 | 0.2 (6) | C5—N1—C8—C9 | −179.3 (3) |
C3—C4—C5—C6 | −1.7 (6) | O1—C8—C9—C10 | 16.6 (5) |
C3—C4—C5—N1 | 177.1 (4) | N1—C8—C9—C10 | −163.9 (3) |
C8—N1—C5—C4 | −100.9 (4) | O1—C8—C9—C11 | −160.1 (3) |
C8—N1—C5—C6 | 77.9 (4) | N1—C8—C9—C11 | 19.4 (5) |
C2—C1—C6—C5 | −0.8 (6) | N2—O2—C10—C9 | 1.4 (4) |
C2—C1—C6—C7 | 175.8 (4) | N2—O2—C10—C12 | −179.2 (3) |
C4—C5—C6—C1 | 2.0 (5) | C11—C9—C10—O2 | −0.7 (4) |
N1—C5—C6—C1 | −176.7 (3) | C8—C9—C10—O2 | −177.9 (3) |
C4—C5—C6—C7 | −174.5 (4) | C11—C9—C10—C12 | −180.0 (4) |
N1—C5—C6—C7 | 6.7 (5) | C8—C9—C10—C12 | 2.8 (6) |
C1—C6—C7—F3 | 114.9 (4) | O2—N2—C11—C9 | 1.2 (4) |
C5—C6—C7—F3 | −68.6 (5) | C10—C9—C11—N2 | −0.4 (4) |
C1—C6—C7—F2 | −5.7 (6) | C8—C9—C11—N2 | 176.9 (3) |
C5—C6—C7—F2 | 170.9 (4) |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1A···O1i | 0.86 | 2.13 | 2.855 (3) | 142 |
Symmetry code: (i) x, −y+1/2, z+1/2. |
Experimental details
Crystal data | |
Chemical formula | C12H9F3N2O2 |
Mr | 270.21 |
Crystal system, space group | Monoclinic, P21/c |
Temperature (K) | 293 |
a, b, c (Å) | 15.839 (3), 8.3260 (17), 9.4250 (19) |
β (°) | 101.29 (3) |
V (Å3) | 1218.9 (4) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.13 |
Crystal size (mm) | 0.20 × 0.10 × 0.10 |
Data collection | |
Diffractometer | Enref–Nonius CAD-4 diffractometer |
Absorption correction | ψ scan (North et al., 1968) |
Tmin, Tmax | 0.974, 0.987 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 2193, 2193, 1125 |
Rint | 0.000 |
(sin θ/λ)max (Å−1) | 0.599 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.062, 0.164, 1.00 |
No. of reflections | 2193 |
No. of parameters | 172 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.19, −0.19 |
Computer programs: CAD-4 EXPRESS (Enraf–Nonius, 1994), XCAD4 (Harms & Wocadlo,1995), SHELXTL (Sheldrick, 2008).
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1A···O1i | 0.86 | 2.13 | 2.855 (3) | 142.3 |
Symmetry code: (i) x, −y+1/2, z+1/2. |
Acknowledgements
The work was supported by the Center for Testing and Analysis, Nanjing University, China.
References
Enraf–Nonius (1994). CAD-4 EXPRESS. Enraf–Nonius. Delft, The Netherlands. Google Scholar
Harms, K. & Wocadlo, S. (1995). XCAD4. University of Marburg, Germany. Google Scholar
Huang, W. H., Yang, C. L., Lee, A. R. & Chiu, H. F. (2003). Chem. Pharm. Bull. 51, 313–314. CrossRef PubMed CAS Google Scholar
North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351–359. CrossRef IUCr Journals Web of Science Google Scholar
Schattenkirchner, M. (2000). Immunopharmacology, 47, 291–298. Web of Science CrossRef PubMed CAS Google Scholar
Shaw, J. J., Chen, B., Wooley, P., Palfey, B., Lee, A. R., Huang, W. H. & Zeng, D. (2011). Am. J. Biomed. Sci. 3, 218–227. CrossRef CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wang, D.-C., Huang, L.-C., Liu, Z.-Y., Wei, P. & Ou-yang, P.-K. (2011). Acta Cryst. E67, o3332. Web of Science CSD CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Leflunomide is one of the most effective isoxazole-containing disease-modifying drugs for treating rheumatoid arthritis (Shaw et al., 2011; Schattenkirchner, 2000). Many leflunomide analogs have been synthesized and exhibit potent immunomodulating effect (Huang, et al., 2003). In our previous work, some anolog has been sucessfully sythesized (Wang et al., 2011). In this paper, one new leflunomide analog N-(2,4-difluorophenyl)-5-methylisoxazole-4-carboxamide monohydrate, was synthesized as a novel and potent immunomodulating drugs. We report herein its crystal structure.
As illustrated in Fig. 1, the molecular structure of the title compound is not planar. The C1-C6 benzene and the C9-C11/N2/O2 isoxazole ring is almost perpendicular to each other with the dihedral angle of 82.97 (2) °. The central nitrogen atom (N1) and carbon atom (C8) are nearly coplanar with the benzene ring and the isoxazole rings [N1-C5-C6-C1 torsion angles = -176.7 (3) ° and C8-C9-C10-O2 torsion angles = -177.9 (3) °], respectively. The length of the C11=N2 double bond is 1.295 (5) Å, slightly longer than standard 1.28 Å value of a C=N double bond. The crystal structure is stabilized by N—H···O hydrogen bonds(Table 1).